614 related articles for article (PubMed ID: 26076857)
21. Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China.
Wang W; Li JM; Hu FY; Wang R; Hong Z; He L; Zhou D
Eur J Neurol; 2016 Mar; 23(3):621-9. PubMed ID: 26563553
[TBL] [Abstract][Full Text] [Related]
22. Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis.
Peng Y; Zheng D; Zhang X; Pan S; Ji T; Zhang J; Shen HY; Wang HH
Front Immunol; 2019; 10():103. PubMed ID: 30792710
[TBL] [Abstract][Full Text] [Related]
23. Does MAP2 have a role in predicting the development of anti-NMDAR encephalitis associated with benign ovarian teratoma? A report of six new pediatric cases.
Cundiff CA; Elawabdeh N; Naguib MM; Jactel SN; Demellawy DE; Abramowsky CR; Durham MM; Youssef L; Wittkamp ML; Shehata BM
Pediatr Dev Pathol; 2015; 18(2):122-6. PubMed ID: 25569473
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal treatment of anti-N-Methyl-D-aspartate receptor encephalitis in children.
Tatencloux S; Chretien P; Rogemond V; Honnorat J; Tardieu M; Deiva K
Dev Med Child Neurol; 2015 Jan; 57(1):95-9. PubMed ID: 25040285
[TBL] [Abstract][Full Text] [Related]
25. High sensitivity and specificity in proposed clinical diagnostic criteria for anti-N-methyl-D-aspartate receptor encephalitis.
Ho ACC; Mohammad SS; Pillai SC; Tantsis E; Jones H; Ho R; Lim M; Hacohen Y; Vincent A; Dale RC
Dev Med Child Neurol; 2017 Dec; 59(12):1256-1260. PubMed ID: 28972277
[TBL] [Abstract][Full Text] [Related]
26. Thyroid Function and Autoimmune Indications in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Ma X; Yin Q; Zeng Z; Wang C; Yang Y; Guo S
Neuroimmunomodulation; 2018; 25(2):110-117. PubMed ID: 30157483
[TBL] [Abstract][Full Text] [Related]
27. Clinical features, treatments, and outcomes of patients with anti-
Xu Q; Zhu Y; Wang Q; Han J; Mao F; Zeng S; Chen S; Zhao C; Gu M; Li Z; Luo X; Fu X; Huang Y
Front Biosci (Landmark Ed); 2021 Sep; 26(9):496-503. PubMed ID: 34590462
[No Abstract] [Full Text] [Related]
28. Analysis of Relation Between Electroclinical Features and Cerebrospinal Fluid Antibody Titers in Patients With anti-NMDAR Encephalitis.
Miao A; Du M; Wang L; Ge J; Lu H; Xu H; Liu H; Yu C; Wu C; Gao Y; Sun J; Shi Q; Wang X
Clin EEG Neurosci; 2019 Jan; 50(1):56-62. PubMed ID: 30246558
[TBL] [Abstract][Full Text] [Related]
29. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.
Zhang Y; Liu G; Jiang M; Chen W; He Y; Su Y
Neurocrit Care; 2018 Oct; 29(2):264-272. PubMed ID: 29651625
[TBL] [Abstract][Full Text] [Related]
30. Lipid Metabolism in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Shu Y; Qin B; Xu Y; Sun X; Chen Z; Wang J; Peng L; Qiu W; Lu Z; Wu A
Neuroimmunomodulation; 2017; 24(4-5):256-263. PubMed ID: 29393234
[TBL] [Abstract][Full Text] [Related]
31. Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
de Montmollin E; Demeret S; Brulé N; Conrad M; Dailler F; Lerolle N; Navellou JC; Schwebel C; Alves M; Cour M; Engrand N; Tonnelier JM; Maury E; Ruckly S; Picard G; Rogemond V; Magalhaes É; Sharshar T; Timsit JF; Honnorat J; Sonneville R;
Am J Respir Crit Care Med; 2017 Feb; 195(4):491-499. PubMed ID: 27552490
[TBL] [Abstract][Full Text] [Related]
32. Anti-NMDAR Encephalitis of 11 Cases in China - Detailed Clinical, Laboratory and Imagiological Description.
Liu J; Wang D; Xiong Y; Liu B; Liu M
Eur Neurol; 2015; 74(1-2):73-8. PubMed ID: 26277996
[TBL] [Abstract][Full Text] [Related]
33. The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
Ai P; Zhang X; Xie Z; Liu G; Liu X; Pan S; Wang H
Acta Neurol Scand; 2018 Feb; 137(2):277-282. PubMed ID: 29023630
[TBL] [Abstract][Full Text] [Related]
34. Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis.
Qin K; Wu W; Huang Y; Xu D; Zhang L; Zheng B; Jiang M; Kou C; Gao J; Li W; Zhang J; Wang S; Luan Y; Yan C; Xu D; Zheng X
BMC Neurol; 2017 Jan; 17(1):1. PubMed ID: 28056870
[TBL] [Abstract][Full Text] [Related]
35. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
[TBL] [Abstract][Full Text] [Related]
36. Anti-N-methyl-D-aspartate receptor encephalitis with accompanying ovarian teratoma in female patients from East China: Clinical features, treatment, and prognostic outcomes.
Zhang L; Lu Y; Xu L; Liu L; Wu X; Zhang Y; Zhu G; Hong Z
Seizure; 2020 Feb; 75():55-62. PubMed ID: 31874360
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis.
Huang Q; Wu Y; Qin R; Wei X; Ma M
J Neurol; 2016 Dec; 263(12):2446-2455. PubMed ID: 27632180
[TBL] [Abstract][Full Text] [Related]
38. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
Front Immunol; 2021; 12():719432. PubMed ID: 34975832
[TBL] [Abstract][Full Text] [Related]
39. Anti-NMDAR encephalitis mimicking HaNDL syndrome.
Finke C; Mengel A; Prüss H; Stöcker W; Meisel A; Ruprecht K
Cephalalgia; 2014 Oct; 34(12):1012-4. PubMed ID: 24619988
[TBL] [Abstract][Full Text] [Related]
40. High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis.
Wang J; Lin J; Wang M; Meng Z; Zhou D; Li J
Front Immunol; 2021; 12():774664. PubMed ID: 34975861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
